Then, we found that the overexpression of PNPO was significantly associated with tumor status in BLCA and GBM, while the overexpression of PNPO was correlated with tumor-free status in KIRC and SARC (sarcoma) (Supplementary Figure S4D). The gene discussed is PNPO; the disease is bladder transitional cell carcinoma.